Strs Ohio Aclaris Therapeutics, Inc. Transaction History

Strs Ohio

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.92 - $1.44 $65,964 - $103,248	71,700 Added 37.15%	264,700 $328,000
Q4 2023 Jan 30, 2024	BUY	$0.64 - $6.49 $88,896 - $901,461	138,900 Added 256.75%	193,000 $202,000
Q2 2023 Jul 31, 2023	BUY	$7.89 - $10.64 $33,138 - $44,688	4,200 Added 8.42%	54,100 $561,000
Q1 2023 Aug 02, 2023	SELL	$7.07 - $17.95 $29,694 - $75,390	-4,200 Reduced 7.76%	49,900 $403,000
Q1 2023 Apr 27, 2023	BUY	$7.07 - $17.95 $95,445 - $242,325	13,500 Added 37.09%	49,900 $403,000
Q4 2022 Jan 26, 2023	BUY	$14.33 - $18.37 $236,445 - $303,105	16,500 Added 82.91%	36,400 $573,000
Q3 2022 Oct 27, 2022	BUY	$13.07 - $18.22 $26,140 - $36,440	2,000 Added 11.17%	19,900 $313,000
Q2 2022 Jul 25, 2022	BUY	$10.16 - $17.08 $181,864 - $305,731	17,900 New	17,900 $249,000
Q4 2021 Jan 24, 2022	SELL	$12.27 - $18.49 $82,209 - $123,882	-6,700 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$13.38 - $18.8 $136,476 - $191,760	-10,200 Reduced 60.36%	6,700 $120,000
Q2 2021 Jul 26, 2021	BUY	$17.08 - $29.6 $288,652 - $500,240	16,900 New	16,900 $296,000

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.